Coronavirus company news summary – STChealth and 1Health.io partner for Covid-19 testing – FDA provides EUA for personal PCR device

22 September 2020 (Last Updated September 22nd, 2020 09:25)

STChealth has partnered with 1Health.io to offer saliva-based Covid-19 tests as part of its strategic alliance to provide a national, comprehensive return-to-work program for employers. STChealth has also partnered with Bridge Purchasing Solutions, Newmark Knight Frank and CuraLinc Healthcare to form ‘The Strategic Actions for Employers (SAFE) Program’, which aims to empower organisations to safeguard their employees amid the Covid-19 pandemic.

CytoSorbents has announced that its CytoSorb blood purification technology that is used to treat cytokine storm and inflammations has received medical device registration from the Brazilian Health Regulatory Agency (ANVISA). With this registration, CytoSorb is available in the country to treat cytokine storm in cardiac surgery and major illnesses including Covid-19. Contatti Medical will distribute the device.

The US Food and Drug Administration (FDA) has issued Emergency Use Authorisation (EUA) for Visby Medical's single-use Personal PCR device, a rapid test to detect Covid-19. The palm-sized device produces results within 30 mins.

Ortho Clinical Diagnostics has announced its continued partnership with the Biomedical Advanced Research and Development Authority (BARDA) under a new contract as a part of the US Government’s and BARDA's effort against the Covid-19 health crisis. Ortho received $12.85m from BARDA to aid its antigen test development and provide regulatory pathway support for total and IgG antibody tests.